As promised, for those who’ve expressed interest, my full recent labwork is below. The numbers in brackets are ‘healthy’ range. Triglycerides & HDL are heading in the wrong direction since keto/carnivore & messed up, as are others. I’ll highlight the bad readings in bold:
Full blood count (424…)
Total white blood count (XaIdY)
5.1 10*9/L [4.2 - 10.6]
Red blood cell count (426…)
4.63 10*12/L [4.23 - 5.46]
Haemoglobin concentration (Xa96v)
145 g/L [130.0 - 168.0]
Haematocrit (X76tb)
0.463 L/L [0.39 - 0.5]
Mean cell volume (42A…)
Above range
99.9 fL [83.5 - 99.5]
Above high reference limit
In an otherwise normal FBC and reticulocyte count, an isolated MCV up
to 104fL can be tolerated without further clinical investigation or
follow up blood film. When macrocytosis is unexpected or unexplained
suggest a repeat FBC after 3 months. If MCV continues to rise, or a
new FBC abnormality is identified, consider a referral to haematology.
For NWLP clinical guidance on raised MCV please refer to:
https://www.nwlondonccg.nhs.uk/professionals/referral-guidelines-and-c
linical-documents/haematology.
Mean cell haemoglobin level (XE2pb)
31.3 pg [27.5 - 33.1]
Mean cell haemoglobin concentration (429…)
Below range
313 g/L [315.0 - 350.0]
Below low reference limit
Red blood cell distribution width (XE2mO)
13.1 % [10.0 - 16.0]
Platelet count - observation (42P…)
186 10*9/L [130.0 - 370.0]
Mean platelet volume (42Z5.)
9.2 fL [8.0 - 12.0]
Nucleated red blood cell count (4266.)
0.0 10*9/L [0.0 - 0.1]
Neutrophil count (42J…)
2.5 10*9/L [2.0 - 7.1]
Lymphocyte count (42M…)
1.9 10*9/L [1.1 - 3.6]
Monocyte count - observation (42N…)
0.4 10*9/L [0.3 - 0.9]
Eosinophil count - observation (42K…)
0.1 10*9/L [0.0 - 0.5]
Basophil count (42L…)
0.0 10*9/L [0.0 - 0.2]
Haemoglobin A1c level - IFCC standardised (XaPbt)
Specimen: BLOOD
Haemoglobin A1c level - IFCC standardised (XaPbt)
36 mmol/mol [20.0 - 41.0]
(NOTE)
HbA1c >=48 mmol/mol: possible diabetes. If patient symptomatic,
diagnosis is confirmed. Consider re-testing HbA1c within 4 weeks if
patient not symptomatic.
HbA1c 42-47 mmol/mol: considered at high risk of developing diabetes.
Consider implementing lifestyle measures.
Comment: HbA1c is accepted for the diagnosis of type 2 diabetes in
the UK, but should not be used to diagnose type 1 diabetes or in the
following contexts: childhood, pregnancy, renal failure,
haemoglobinopathy trait, anaemia, HIV, abnormal red-cell turnover,
or any recent treatment likely to affect glycaemia or red-cell
turnover.
In cases of confirmed Type 2 diabetes mellitus, NICE CG66 treatment
target HbA1c is 48-59 mmol/mol
Liver function tests (X77WP)
Specimen: BLOOD
Liver function tests (X77WP)
Serum alanine aminotransferase level (XaLJx)
23 U/L [0.0 - 45.0]
Serum bilirubin level (44E…)
11 umol/L [0.0 - 21.0]
Serum alkaline phosphatase level (XE2px)
73 U/L [30.0 - 130.0]
Serum albumin level (XE2eA)
41 g/L [35.0 - 50.0]
Serum lipid levels (XE2q7)
Specimen: BLOOD
Serum cholesterol level (XE2eD)
8.2 mmol/L
(NOTE)
In primary prevention, lipid results should be assessed in tandem
with other risk factors to estimate cardiovascular disease (CVD)
risk. NICE recommend using the QRISK2 calculator In primary
prevention, lipid results should be assessed in tandem with other
risk factors to estimate cardiovascular disease (CVD) risk. NICE
recommend using the QRISK2 calculator
https://www.qrisk.org/2017/
When considering treatment for primary prevention of CVD in
individuals with ?10% risk, share the option to have treatment or
not before prescribing. Patient decision aids include:
http://www.jbs3risk.com/JBS3Risk.swf
https://www.nice.org.uk/guidance/cg181/resources/patient-decision-aid-
pdf-243780159
Non-HDL cholesterol (total chol minus HDL chol) is recommended for
CVD risk prediction; fasting samples are not required for this.
Non-HDL cholesterol targets for patients treated for CVD risk
reduction are:
- 40 % reduction from baseline (NICE CG181, 2014) or
- < 2.5 mmol/L (JBS3. Heart 2014:100:ii1)
Once a patient has reached their target level of cholesterol, there
is no need to keep measuring it.
Significant dyslipidaemia, seek specialist advice.
Serum triglyceride levels (XE2q9)
Above range
2.03 mmol/L [< 1.7]
Above high reference limit
Serum HDL cholesterol level (44P5.)
Below range
0.85 mmol/L [> 1.0]
Below low reference limit
Serum LDL cholesterol level (44P6.)
above range
6.43 mmol/L
Consider familial hypercholesterolaemia, exclude other causes and seek specialist advice if necessary
Serum cholesterol/HDL ratio (XaEUq)
Above range
9.65 [< 5.0]
Above high reference limit
Serum non high density lipoprotein cholesterol level (XabE1)
7.4 mmol/L
Renal function tests (451…)
Specimen: BLOOD
Serum sodium level (XE2q0)
135 mmol/L [133.0 - 146.0]
Serum potassium level (XE2pz)
4.0 mmol/L [3.5 - 5.3]
Serum creatinine level (XE2q5)
85 umol/L [60.0 - 125.0]
eGFR using creatinine (CKD-EPI) per 1.73 square metres (XacUK)
over 90 mL/min/1.73m2 [> 89.0]
Serum vitamin B12 level (XE2pf)
Specimen: BLOOD
Serum vitamin B12 level (XE2pf)
414 ng/L [160.0 - 800.0]
Serum folate level (42U5.)
Specimen: BLOOD
Serum folate level (42U5.)
4.4 ug/L [> 2.7]
Serum TSH level (XaELV)
Specimen: BLOOD
Serum TSH level (XaELV)
1.37 mU/L [0.3 - 4.2]
Serum total 25-hydroxy vitamin D level (Xabo0)
Specimen: BLOOD
Serum total 25-hydroxy vitamin D level (Xabo0)
73.9 nmol/L [50.0 - 150.0]
(NOTE)
Recommendations for Bone Health
Deficient = < 25
Insufficient = 25-50
Replete = 50-150
This method underestimates vitamin D2.
If patient is taking D2 or unknown vitamin D replacement, please
request D2/D3 assay.